pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

arecor PRESS RELEASE ARCHIVE

Jul 20, 2023

Arecor: Business Update

Aug 1, 2022

Xeris’ Commercialization Partner for Ogluo, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics

May 18, 2022

ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CARE

Apr 28, 2022

ARECOR PRESENTS FULL DATA FROM POSITIVE PHASE I CLINICAL TRIAL OF AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN FOR DIABETES AT ATTD MEETING

Apr 12, 2022

Arecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for Diabetes

Apr 12, 2022

Mar 23, 2022

ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS

Jan 20, 2022

ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT247 ULTRA-RAPID INSULIN IN COMBINATION WITH AN INSULIN PUMP

Jan 20, 2022

ARECOR COMMENCES US PHASE I CLINICAL TRIAL OF AT247 ULTRA-RAPID INSULIN IN COMBINATION WITH AN INSULIN PUMP

Nov 1, 2021

ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY COLLABORATION WITH A LEADING GLOBAL MEDICAL PRODUCTS COMPANY TO DEVELOP A STABLE READY TO ADMINISTER PRODUCT

Sep 20, 2021

Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes

May 20, 2021

Arecor Announces an Exclusive Formulation Study Collaboration With Lilly

Mar 31, 2021

Arecor Receives £2.8 Million Grant Award From Innovate UK

Dec 17, 2020

Arecor's Partner Inhibrx Exercises Its Option to License a New Formulation Developed by Arecor in Accordance With the Terms of Formulation Development Agreement

Dec 16, 2020

Arecor Announces Publication of Phase I Data for AT247 in Diabetes Care

Dec 15, 2020

Arecor Limited: First Patient Dosed in Phase I Clinical Trial of Ultra-Concentrated Rapid Acting Insulin Candidate, AT278, for Diabetes

Oct 20, 2020

Hikma and Arecor Expand Collaboration

Oct 20, 2020

Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine

Sep 21, 2020

Arecor to Present at EASD 2020

Jun 15, 2020

Arecor announces Phase 1 of AT247 at ADA

Mar 19, 2020

ARECOR EXTENDS MULTI-PRODUCT COLLABORATION WITH CLINICAL STAGE BIOTECH

Feb 25, 2020

Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner

Jan 9, 2020

Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ Technology

Jan 9, 2020

Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology

Dec 5, 2019

Arecor Announces Positive Headline Results for the First Phase I Clinical Trial of AT247, a Novel Ultra Rapid Acting Formulation of Insulin

Jul 25, 2016

JDRF Announces Partnership with Arecor Ltd to Support Development of a Stable, Rapid-Acting, Ultra-Concentrated Insulin

Jul 30, 2013

FluGen-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award from the UK’s innovation agency, the Technology Strategy Board

Dec 20, 2011

Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics

Jun 14, 2011

Arecor and GSK Form Collaboration to Advance New Vaccines

Jun 14, 2011

Arecor und GSK gehen Zusammenarbeit zur Fortentwicklung neuer Impfstoffe ein

Jun 14, 2011

Arecor et GSK collaborent pour la création de nouveaux vaccins

Apr 26, 2011

COMPASS BIOTECHNOLOGIES (COBI:OB) ANNOUNCES MEMORANDUM OF UNDERSTANDING WITH ARECOR LTD., OF CAMBRIDGE U.K. TO DEVELOP HEAT STABLE HEPATITIS B VACCINE

Google Analytics Alternative